Save up to $200
on SANCUSO after
paying the first $30.
Talk to your healthcare professional to see if SANCUSO is right for you.
Be proactive. Prevent CINV before it even starts. Use SANCUSO.
Risk factors
If you have any of these risk factors, see if SANCUSO can help. Then print out the questions and discuss with your healthcare professional.
Personal characteristics that increase your risk of CINV3,4
Acute CINV
Delayed CINV
Younger age Female Poor control of symptoms in prior cycles History of motion sickness History of nausea with pregnancy Anxiety Depression Absence of alcoholism Expectation of CINV |
Female Poor control of acute CINV symptoms Expectation of CINV History of severe nausea with pregnancy |
Certain chemotherapy regimens are more likely to cause CINV2
Greater than 90% chance of developing CINV
30% to 90% chance of developing CINV
AC (doxorubicin or epirubicin with cyclophosphamide) Carmustine >250 mg/m2 Cisplatin ≥50 mg/m2 Cyclophosphamide >1500 mg/m2 Dacarbazine Mechlorethamine Streptozocin |
Aldesleukin >12-15 million IU/m2 Amifostine >300 mg/m2 Arsenic trioxide Azacitidine Bendamustine Busulfan >4 mg/d Carboplatin Carmustine ≤250 mg/m2 Cisplatin <50 mg/m2 Clofarabine Cyclophosphamide ≤1500 mg/m2 Cytarabine >200 mg/m2 Dactinomycin Daunorubicin Doxorubicin Epirubicin Idarubicin Ifosfamide Interferon alfa >10 million IU/m2 Irinotecan Melphalan >50 mg/m2 Methotrexate 250-1000 mg/m2 Oxaliplatin >75 mg/m2 Temozolomide |
© 2010 ProStrakan, Inc.
All rights reserved.
